| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/04/2004 | EP1385979A2 Method for enhancing the translation and expression of recombinant proteins |
| 02/04/2004 | EP1385975A2 Method for the production of d-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs |
| 02/04/2004 | EP1385974A2 Method for the production of an aqueous acrylamide solution with a bio-catalyst |
| 02/04/2004 | EP1385972A2 Method for producing an aqueous acrylamide solution with a biocatalyst |
| 02/04/2004 | EP1385944A2 Improved process for converting nitriles to carboxylic acids using nitrilase |
| 02/04/2004 | EP1385943A2 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1107799B1 Method for labeling biopolymers using isotopes |
| 02/04/2004 | EP0974268B1 Bifidobacterium-fermented milk and process for producing the same |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | EP0670848B1 High molecular weight collagen-like protein polymers |
| 02/04/2004 | CN1473199A Method for obtaining 12-hydroxystearic acid |
| 02/04/2004 | CN1137254C Detergent composition |
| 02/03/2004 | US6686452 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |
| 02/03/2004 | US6686448 Class II cytokine receptor-7 |
| 02/03/2004 | US6686439 Polyhydroxyalkanoate for use in culturing microorganisms |
| 02/03/2004 | US6686195 Method and apparatus for ultrasonic lysis of biological cells |
| 02/03/2004 | US6686190 Methods for enhancing the production of viral vaccines in cell culture |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686075 Reforming organic fuel in fuel cell; bioreactor containing thermophilic microorganisms |
| 02/03/2004 | US6685946 Cold-adapted equine influenza viruses |
| 02/03/2004 | US6685936 Administering lymphocytes |
| 02/03/2004 | CA2123496C A bacillus promoter derived from a variant of a bacillus licheniforms x-amylase promoter |
| 02/03/2004 | CA2095735C Monoclonal antibodies to hepatitis c virus and method for using same |
| 02/03/2004 | CA2091636C Method for suppressing coloring of human serum albumin |
| 02/03/2004 | CA2025597C Vaccine against lyme disease |
| 01/29/2004 | WO2004009827A2 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/29/2004 | WO2003018825A3 Method for producing vitamin b12 |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | DE19964268B4 Verfahren zum Screenen einer Verbindung, welche die Wechselwirkung zwischen IGF-1R und einem der Polypeptide IIP-1 bis IIP-10 hemmt A method for screening a compound which inhibits the interaction between IGF-1R and IIP-one of the polypeptides 1 to IIP-10 |
| 01/29/2004 | CA2489982A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/28/2004 | EP1383901A1 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current |
| 01/28/2004 | EP1383795A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/28/2004 | EP0974658B1 Probes for the diagnosis of infections caused by streptococcus pyogenes |
| 01/28/2004 | EP0973869B1 Method for increasing the growth of plant cell cultures |
| 01/28/2004 | EP0972833B1 Probes for the diagnosis of infections caused by klebsiella pneumoniae |
| 01/28/2004 | EP0842290B1 Process for the preparation of lovastatin |
| 01/28/2004 | EP0636030B1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/28/2004 | CN1471582A Methods for producing a polypeptide using a consensus translational initiator sequence |
| 01/28/2004 | CN1471576A Immortalized preosteoblasts and method for their production |
| 01/28/2004 | CN1136315C Purified polyporus laccases and nucleic acids encoding same |
| 01/28/2004 | CN1136314C Gene for transcription factor capable of altering characters of plants and use thereof |
| 01/28/2004 | CN1136311C Subtilase variants and compositions |
| 01/28/2004 | CN1136310C D-sorbitol dehydrogenase |
| 01/28/2004 | CN1136008C Method for detection of i (legioneela) bacteria employing purified entigen-specific antibodies |
| 01/28/2004 | CN1135925C Method for preparing biological rodenticide and composition obtained thereby |
| 01/27/2004 | US6683231 High level production of p-hydroxybenzoic acid in green plants |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683059 Constructs for suppression of oncogenic transformation, tumorigenesis and metastasis |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | CA2080428C A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007404A1 Mineral and bioorganic additive for plant growth and development |
| 01/22/2004 | WO2004006851A2 Mycoplasma gallisepticum formulation |
| 01/22/2004 | WO2003067213A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016020 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/22/2004 | US20040014703 Aqueous solution containing cationic stabilizer |
| 01/22/2004 | US20040014198 Non-revertible beta-oxidation blocked candida tropicalis |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014184 Method for obtaining 12-hydroxystearic acid |
| 01/22/2004 | US20040014175 Producting proteases which differ from wild type in at least one amino acid for use in industrial and food applications such as textile treatment, detergents and protein degradation |
| 01/22/2004 | US20040014123 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/21/2004 | EP1382686A1 Method for producing target substance by fermentation using a bacterial strain lacking the ArcA gene |
| 01/21/2004 | EP1382684A1 Process for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382674A2 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382346A1 Conditioned medium and diffusible biological product produced by incubating entrapped cells |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP0728213B1 Transgenic fructan accumulating crops and methods for their production |
| 01/21/2004 | CN1469929A Method of modifying microorganism-origin transglutaminase |
| 01/21/2004 | CN1469928A Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
| 01/21/2004 | CN1469751A Medicinal compositions for promoting recovery from stress loading and novel matsutake mushroom strain |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680190 Gene encoding phosphoglucoisomerase |
| 01/20/2004 | US6680182 Promoter sequence operably linked to a dna sequence encoding first and second proteins linked by hinge regiion; tetanus toxin c fragments |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | CA2210753C Farnesyl diphosphate synthase |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/20/2004 | CA2078235C Idiotypic vaccination against b cell lymphoma |
| 01/19/2004 | CA2433485A1 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |